Almustat was founded in Brussels, Belgium, in 1991 by Marc Buyse, ScD.
With over 30 years of experience, Almustat has become a trusted partner in clinical research, offering expertise in study design, conduct, and analysis. Our services include regulatory statistics, optimal study designs, cutting-edge integrated web systems, and innovative statistical methodologies that streamline clinical trial processes, saving both time and costs.
As clinical trials grow more complex, partnering with someone reliable is crucial. At Almustat, we help you make informed data-driven decisions, reduce risks, and enhance the quality of your study submissions, ensuring success at every phase.
The International Institute for Drug Development (ID2) was established in Brussels (Belgium) in 1991 by Marc Buyse ScD.
The company expanded its client base in France and opened an office in Paris to ensure proximity to its French clients.
The company was renamed IDDI, International Drug Development Institute. An office was opened in Cambridge, Massachusetts, to offer advanced web-based services for clinical research supported by a dedicated help desk to cover the American time zones. Business development and Finance still operate out of Cambridge, MA to serve IDDI’s American clients.
Closed Paris office and consolidated European team in Belgium.
Moved headquarter to Louvain-la-Neuve.
IDDI opened a new office in Houston Texas. Operational team in the US.
Creation of a new branch, CluePoints, dedicated to Central Statistical Monitoring applied to clinical trials.
IDDI opens a new office in Raleigh in October 2014 and provides Data Management, Biostatistics and Project Management staff to serve US based clients.
IDDI opens a new office in Raleigh in October 2014 and provides Data Management, Biostatistics and Project Management staff to serve US based clients.
Getting an accurate diagnosis can be one of the most impactful experiences that you can have.
Copyright © 2024 Almustat.com